AlphaNavi Pharma specializes in the research and development of new drugs.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 5, 2019 | Series A | ¥0.90B | 2 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series A |
|
|
— | Series A |